Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantification of lean bodyweight.

Sarayut Janmahasatian1, Stephen B Duffull, Susan Ash

  • 1School of Pharmacy, University of Queensland, Brisbane, Queensland, Australia.

Clinical Pharmacokinetics
|September 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Life-course trajectories of cardiovascular disease risk factors in rural India: Andhra Pradesh Children and Parents Study (APCAPS) 2003-2023.

International journal of epidemiology·2026
Same author

Beyond reliability: Addressing systematic bias and advancing standardization in bioelectrical impedance analysis.

European journal of clinical nutrition·2026
Same author

Telling the good story: supporting children's first 1,000 days in Northwest Tasmania.

International journal of qualitative studies on health and well-being·2026
Same author

Integrating machine learning for advanced analysis of bioelectrical impedance parameters in children with nephrotic syndrome.

Frontiers in pediatrics·2026
Same author

Implementing body composition assessment into clinical practice in patients with acute spinal cord injury- a pilot feasibility study.

Spinal cord·2026
Same author

Comparison of air displacement plethysmography, dual-energy X-ray absorptiometry, and bioimpedance in 6-week-old and 6-month-old infants.

Pediatric research·2025

A new semi-mechanistic model accurately predicts fat-free mass (FFM), closely approximating lean bodyweight (LBW), using simple patient characteristics. This model offers improved dosing for medications across diverse body sizes.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Biomedical Engineering
  • Anthropometry

Background:

  • Lean bodyweight (LBW) is crucial for accurate drug dosing.
  • Current LBW prediction methods are unreliable, especially for individuals at size extremes.
  • Inconsistent LBW estimations can lead to misleading weight-based drug regimens.

Purpose of the Study:

  • To develop a semi-mechanistic model for predicting fat-free mass (FFM), a proxy for LBW.
  • To ensure the model performs accurately across a wide range of patient sizes.
  • To provide a reliable method for estimating LBW for clinical applications.

Main Methods:

  • Developed a two-stage semi-mechanistic model using anthropometric data from 373 patients.
  • Stage 1: Modeled impedance prediction using sex, height, and bodyweight.

Related Experiment Videos

  • Stage 2: Modeled FFM prediction incorporating predicted impedance; externally validated in a separate patient cohort.

    • Main Results:

    • The impedance prediction model showed good performance (r² = 0.78).
    • The final FFM prediction model, using sex, height, and bodyweight, demonstrated high accuracy (r² = 0.93, RMSE ≈ 6% of mean).
    • External validation confirmed the model's predictive capability (r² = 0.85, RMSE ≈ 7% of mean).

    Conclusions:

    • A robust semi-mechanistic model for predicting FFM (and thus LBW) has been successfully developed.
    • The model utilizes readily available patient characteristics for ease of clinical use.
    • Prospective evaluation confirmed the model's strong predictive performance and clinical utility.